No Data
No Data
Olympia Pharmaceuticals Announces the Launch of Sister Brand, Wesley Pharmaceuticals, in Honor of Beloved Employee
VITAS Healthcare Unveils Inpatient Hospice Unit at Franciscan Health Olympia Fields
Express News | Lynparza Shows Significant Survival Benefit In Early Breast Cancer In OlympiA Phase III Trial; Reduces Risk Of Death By 28% And Recurrence By 35% At Six Years, Becoming First PARP Inhibitor To Improve Survival In Early Breast Cancer
LYNPARZA (Olaparib) Demonstrated Clinically Meaningful Prolonged Survival Benefit in Early Breast Cancer in OlympiA Phase III Trial
Olympia Financial Group Inc. Announces December Dividend
Express News | OLYMPIA Reports FY24Q3 Revenue of RM21.4 Million
No Data